Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Studying Human Cognition During Deep Brain Stimulation Surgery Using COBENFY
NCT07721272Phase 1Not yet recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Oct 2026
- Primary completion
- Sep 2030
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of trospium in memory disorder (4 arms), sponsored by UT Southwestern Medical Center. Primary endpoints: Cognitive control task-related changes in brain electrical activity, Memory task-related changes in brain electrical activity and 3 more. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
trospium
03
Conditions
memory disorder
Beyond the preview
Go deeper on NCT07721272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07721272.